$18.61
1.17% today
NYSE, Nov 20, 10:00 pm CET
ISIN
US87911J1034
Symbol
HQH

Tekla Healthcare Investors Stock price

$18.83
-0.36 1.88% 1M
+2.97 18.73% 6M
+2.78 17.32% YTD
+1.20 6.81% 1Y
-0.09 0.48% 3Y
-2.75 12.76% 5Y
-12.58 40.04% 10Y
+1.41 8.09% 20Y
NYSE, Closing price Wed, Nov 19 2025
-0.05 0.26%
ISIN
US87911J1034
Symbol
HQH

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
$0.0
Cash
-
Shares outstanding
54.0m
Valuation (TTM | estimate)
P/E
94.2 | -
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
$2.24
Yield 1Y | 5Y
11.9% | 10.1%
Growth 1Y | 5Y
9.8% | 4.8%
Payout 1Y | 3Y
57.5% | 928.8%
Increased
2 Years
Financials (TTM | estimate)
Revenue
$10.2m | -
EBITDA
- | -
EBIT
$-1.1m | -
Net Income
$10.0m | -
Free Cash Flow
$-72.1m
Growth (TTM | estimate)
Revenue
2.2% | -
EBITDA
- | -
EBIT
0.0% | -
Net Income
-86.3% | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
-5.3%
EBITDA
- | -
EBIT
-10.8%
Net
98.1% | -
Free Cash Flow
-707.7%
Financial Health
Equity Ratio
99.9%
Return on Equity
17.5%
ROCE
-0.1%
ROIC
-
Debt/Equity
0.0
More
EPS
$0.2
FCF per Share
$-1.3
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Tekla Healthcare Investors a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

Financial data from Tekla Healthcare Investors

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
10 10
2% 2%
100%
- Direct Costs 11 11
3% 3%
105%
-0.54 -0.54
35% 35%
-5%
- Selling and Administrative Expenses 0.44 0.44
17% 17%
4%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -1.10 -1.10
0% 0%
-11%
Net Profit 10 10
86% 86%
98%

In millions USD.

Don't miss a Thing! We will send you all news about Tekla Healthcare Investors directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tekla Healthcare Investors Stock News

Positive
Seeking Alpha
3 days ago
abrdn Healthcare Investors offers a discounted entry into the healthcare sector, with a strong tilt toward biotechnology exposure and active management. HQH has recently outperformed both the S&P 500 and biotech benchmarks, driven by relatively smaller-cap or lesser-known holdings like QURE, ALNY, ARGX, and CYTK. HQH suits more aggressive investors comfortable with volatility over the long term...
Neutral
PRNewsWire
9 days ago
PHILADELPHIA , Nov. 11, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, FCO, IAF, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on November 28, 2025 to all shareholders of record as of November 21, ...
Neutral
Seeking Alpha
12 days ago
abrdn Healthcare Investors is downgraded to a sell due to persistent underperformance and heavy concentration in Biotechnology. HQH offers a high dividend yield of 11.3%, but its income focus comes at the expense of long-term capital appreciation and NAV growth. Peers like THQ and THW provide better diversification across healthcare sub-sectors and have delivered superior total returns over the...
More Tekla Healthcare Investors News

Company Profile

Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.

Head office United States
Founded 1986
Website www.abrdnhqh.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today